Company news
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) news
Iovance Biotherapeutics, Inc. news releases on 6ix. Latest, Jan 12, 2020: Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2…
Press releases — page 3
Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog
January 11, 2020
Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy
November 20, 2019
Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer 34th Annual Meeting
November 7, 2019
Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results
November 3, 2019
Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting
October 1, 2019